To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect.

HR 5629 would prevent the Department of Health and Human Services' final rule on opioid treatment medications from taking effect, except for changes to accreditation standards for opioid treatment programs. The rule, published in February 2024, aimed to expand access to certain medications for opioid use disorder by modifying treatment protocols. This bill would maintain current regulations for medication-assisted treatment by blocking the rule's implementation, while leaving accreditation requirements unchanged. As a result, existing treatment guidelines would remain in place, but program accreditation standards would still be updated per the rule's exception.